Adtalem Global Education (NYSE:CVSA) Upgraded to "Buy" at Wall Street Zen

Key Points

• Wall Street Zen upgraded Adtalem Global Education from “hold” to “buy,” contributing to an overall “Moderate Buy” consensus rating and an average analyst price target of $155.
• Adtalem shares were up 13.3%, opening at $140.84, while the company reported quarterly EPS of $2.09, beating consensus expectations of $1.90 on revenue of $501.38 million.
• Company insiders sold 15,694 shares worth approximately $2.1 million over the past three months, although the disclosed transactions were conducted under pre-arranged Rule 10b5-1 trading plans.

Adtalem Global Education (NYSE:CVSA - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a report released on Saturday.

CVSA has been the topic of a number of other reports. Barrington Research restated an "outperform" rating and issued a $170.00 price target on shares of Adtalem Global Education in a research note on Monday, June 8th. Truist Financial increased their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Monday, May 11th. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $155.00.

Adtalem Global Education Stock Up 13.3%

Shares of NYSE:CVSA opened at $140.84 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70. The firm has a market capitalization of $4.79 billion, a P/E ratio of 20.01, a P/E/G ratio of 0.94 and a beta of 0.62. Adtalem Global Education has a 52 week low of $86.97 and a 52 week high of $156.26. The firm has a 50-day moving average price of $124.68.

Adtalem Global Education (NYSE:CVSA - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.19. Adtalem Global Education had a return on equity of 21.05% and a net margin of 12.87%.The company had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Analysts expect that Adtalem Global Education will post 8.85 EPS for the current year.

Insiders Place Their Bets

In other Adtalem Global Education news, CEO Stephen W. Beard sold 2,762 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $130.14, for a total value of $359,446.68. Following the completion of the transaction, the chief executive officer directly owned 426,562 shares of the company's stock, valued at approximately $55,512,778.68. This trade represents a 0.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Douglas G. Beck sold 2,650 shares of the business's stock in a transaction that occurred on Tuesday, July 7th. The stock was sold at an average price of $135.40, for a total value of $358,810.00. Following the sale, the senior vice president directly owned 35,509 shares in the company, valued at $4,807,918.60. This trade represents a 6.94% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 15,694 shares of company stock worth $2,098,614. 2.50% of the stock is owned by company insiders.

About Adtalem Global Education

Adtalem Global Education NYSE: CVSA is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source